Question

A 28-year-old at substantial risk for HIV acquisition through receptive vaginal sex requests PrEP. Which option is NOT indicated for this exposure?

Accepted Answer

Tenofovir alafenamide/emtricitabine (TAF/FTC) daily

Answer

Tenofovir disoproxil/emtricitabine (TDF/FTC) daily

Answer

Long-acting cabotegravir IM every 2 months

Answer

Comprehensive risk-reduction plus STI screening

Answer

On-demand (2-1-1) TDF/FTC for receptive vaginal sex

Practice question

A 28-year-old at substantial risk for HIV acquisition through receptive vaginal sex requests PrEP. Which option is NOT indicated for this exposure?